Medication Adherence Measures: An Overview

Wai Yin Lam, Paula Fresco, Wai Yin Lam, Paula Fresco

Abstract

WHO reported that adherence among patients with chronic diseases averages only 50% in developed countries. This is recognized as a significant public health issue, since medication nonadherence leads to poor health outcomes and increased healthcare costs. Improving medication adherence is, therefore, crucial and revealed on many studies, suggesting interventions can improve medication adherence. One significant aspect of the strategies to improve medication adherence is to understand its magnitude. However, there is a lack of general guidance for researchers and healthcare professionals to choose the appropriate tools that can explore the extent of medication adherence and the reasons behind this problem in order to orchestrate subsequent interventions. This paper reviews both subjective and objective medication adherence measures, including direct measures, those involving secondary database analysis, electronic medication packaging (EMP) devices, pill count, and clinician assessments and self-report. Subjective measures generally provide explanations for patient's nonadherence whereas objective measures contribute to a more precise record of patient's medication-taking behavior. While choosing a suitable approach, researchers and healthcare professionals should balance the reliability and practicality, especially cost effectiveness, for their purpose. Meanwhile, because a perfect measure does not exist, a multimeasure approach seems to be the best solution currently.

References

    1. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
    1. Brown M. T., Bussell J. K. Medication adherence: WHO cares? Mayo Clinic Proceedings. 2011;86(4):304–314. doi: 10.4065/mcp.2010.0575.
    1. Johnson M. J., Williams M., Marshall E. S. Adherent and nonadherent medication-taking in elderly hypertensive patients. Clinical Nursing Research. 1999;8(4):318–335. doi: 10.1177/10547739922158331.
    1. Lavsa S. M., Holzworth A., Ansani N. T. Selection of a validated scale for measuring medication adherence. Journal of the American Pharmacists Association. 2011;51(1):90–94. doi: 10.1331/JAPhA.2011.09154.
    1. Svarstad B. L., Chewning B. A., Sleath B. L., Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Education & Counseling. 1999;37(2):113–124. doi: 10.1016/s0738-3991(98)00107-4.
    1. McDonnell P. J., Jacobs M. R., Monsanto H. A., Kaiser J.-M. Hospital admissions resulting from preventable adverse drug reactions. Annals of Pharmacotherapy. 2002;36(9):1331–1336. doi: 10.1345/aph.1a333.
    1. Osterberg L., Blaschke T. Adherence to medication. The New England Journal of Medicine. 2005;353(5):487–497. doi: 10.1056/nejmra050100.
    1. Vrijens B., de Geest S., Hughes D. A., et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology. 2012;73(5):691–705. doi: 10.1111/j.1365-2125.2012.04167.x.
    1. Fischer M. A., Stedman M. R., Lii J., et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. Journal of General Internal Medicine. 2010;25(4):284–290. doi: 10.1007/s11606-010-1253-9.
    1. Solomon M. D., Majumdar S. R. Primary non-adherence of medications: lifting the veil on prescription-filling behaviors. Journal of General Internal Medicine. 2010;25(4):280–281. doi: 10.1007/s11606-010-1286-0.
    1. Lehane E., McCarthy G. Medication non-adherence—exploring the conceptual mire. International Journal of Nursing Practice. 2009;15(1):25–31. doi: 10.1111/j.1440-172x.2008.01722.x.
    1. Sackett D. L., Haynes R. B., Gibson E. S. Patient compliance with antihypertensive regimens. Patient Counselling and Health Education. 1978;1(1):18–21. doi: 10.1016/S0738-3991(78)80033-0.
    1. Vermeire E., Hearnshaw H., Van Royen P., Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics. 2001;26(5):331–342. doi: 10.1046/j.1365-2710.2001.00363.x.
    1. Steiner J. F., Earnest M. A. The language of medication-taking. Annals of Internal Medicine. 2000;132(11):926–930. doi: 10.7326/0003-4819-132-11-200006060-00026.
    1. Farmer K. C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics. 1999;21(6):1074–1090. doi: 10.1016/s0149-2918(99)80026-5.
    1. Hurley F., Cramer J., Spilker B. Patient Compliance in Medical Practice and Clinical Trials. Raven Press; 1991. Statistical approach to subgroup analyses: patient compliance data and clinical outcomes; pp. 243–250.
    1. Vitolins M. Z., Rand C. S., Rapp S. R., Ribisl P. M., Sevick M. A. Measuring adherence to behavioral and medical interventions. Controlled Clinical Trials. 2000;21(5, supplement):188S–194S.
    1. Velligan D. I., Wang M., Diamond P., et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatric Services. 2007;58(9):1187–1192. doi: 10.1176/appi.ps.58.9.1187.
    1. Vik S. A., Maxwell C. J., Hogan D. B. Measurement, correlates, and health outcomes of medication adherence among seniors. Annals of Pharmacotherapy. 2004;38(2):303–312. doi: 10.1345/aph.1d252.
    1. Dew M. A., Dabbs A. D., Myaskovsky L., et al. Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation. 2009;88(5):736–746. doi: 10.1097/tp.0b013e3181b2a0e0.
    1. Ho P. M., Bryson C. L., Rumsfeld J. S. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–3035. doi: 10.1161/circulationaha.108.768986.
    1. Jimmy B., Jose J. Patient medication adherence: measures in daily practice. Oman Medical Journal. 2011;26(3):155–159. doi: 10.5001/omj.2011.38.
    1. Diaz E., Levine H. B., Sullivan M. C., et al. Use of the medication event monitoring system to estimate medication compliance in patients with schizophrenia. Journal of Psychiatry and Neuroscience. 2001;26(4):325–329.
    1. Cramer J. A., Scheyer R. D., Mattson R. H. Compliance declines between clinic visits. Archives of Internal Medicine. 1990;150(7):1509–1510. doi: 10.1001/archinte.150.7.1509.
    1. Modi A. C., Ingerski L. M., Rausch J. R., Glauser T. A., Drotar D. White coat adherence over the first year of therapy in pediatric epilepsy. The Journal of Pediatrics. 2012;161(4):695–699.e1. doi: 10.1016/j.jpeds.2012.03.059.
    1. Downie R. S. Clinical Judgement: Evidence in Practice. Oxford, UK: Oxford University Press; 2000. (edited by: J. Macnaughton, F. Randall).
    1. Steiner J. F., Prochazka A. V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. Journal of Clinical Epidemiology. 1997;50(1):105–116. doi: 10.1016/s0895-4356(96)00268-5.
    1. Hess L. M., Raebel M. A., Conner D. A., Malone D. C. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Annals of Pharmacotherapy. 2006;40(7-8):1280–1288. doi: 10.1345/aph.1h018.
    1. Barner J. Medication Adherence: Focus on Secondary Database Analysis. ISPOR Student Forum; 2010.
    1. Kitahata M. M., Reed S. D., Dillingham P. W., et al. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. International Journal of STD and AIDS. 2004;15(12):803–810. doi: 10.1258/0956462042563666.
    1. Krousel-Wood M., Holt E., Joyce C., et al. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO) Journal of Hypertension. 2015;33(2):412–420. doi: 10.1097/hjh.0000000000000382.
    1. Andrade S. E., Kahler K. H., Frech F., Chan K. A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology and Drug Safety. 2006;15(8):565–574. doi: 10.1002/pds.1230.
    1. Vanderpoel D. R., Hussein M. A., Watson-Heidari T., Perry A. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Clinical Therapeutics. 2004;26(12):2066–2075. doi: 10.1016/j.clinthera.2004.12.018.
    1. DiMatteo M. R., Giordani P. J., Lepper H. S., Croghan T. W. Patient adherence and medical treatment outcomes: a meta-analysis. Medical Care. 2002;40(9):794–811. doi: 10.1097/00005650-200209000-00009.
    1. Checchi K. D., Huybrechts K. F., Avorn J., Kesselheim A. S. Electronic medication packaging devices and medication adherence: a systematic review. The Journal of the American Medical Association. 2014;312(12):1237–1247. doi: 10.1001/jama.2014.10059.
    1. van Onzenoort H. A. W., Verberk W. J., Kessels A. G. H., et al. Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. The American Journal of Hypertension. 2010;23(2):149–154. doi: 10.1038/ajh.2009.207.
    1. Lee J. Y., Kusek J. W., Greene P. G., et al. Assessing medication adherence by pill count and electronic monitoring in the African American study of kidney disease and hypertension (AASK) pilot study. American Journal of Hypertension. 1996;9(8):719–725. doi: 10.1016/0895-7061(96)00056-8.
    1. Nguyen T.-M., Caze A. L., Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. British Journal of Clinical Pharmacology. 2014;77(3):427–445. doi: 10.1111/bcp.12194.
    1. Morisky D. E., Ang A., Krousel-Wood M., Ward H. J. Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension. 2008;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x.
    1. Straka R. J., Fish J. T., Benson S. R., Suh J. T. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy. 1997;17(1):126–132.
    1. Miller W. R., Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. Guilford Press; 1991.
    1. Kavookjian J. PSAP-VII Book 8 (Science and Practice of Pharmacotherapy) Lenexa, Kan, USA: American College of Clinical Pharmacy; 2011. Motivational interviewing.
    1. Rubak S., Sandbæk A., Lauritzen T., Christensen B. Motivational interviewing: a systematic review and meta-analysis. British Journal of General Practice. 2005;55(513):305–312.
    1. Tan X., Patel I., Chang J. Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8) Innovations in Pharmacy. 2014;5(3):p. 165.
    1. Kim M. T., Hill M. N., Bone L. R., Levine D. M. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Progress in cardiovascular nursing. 2000;15(3):90–96. doi: 10.1111/j.1751-7117.2000.tb00211.x.
    1. Lambert E. V., Steyn K., Stender S., Everage N., Fourie J. M., Hill M. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethnicity and Disease. 2006;16(1):286–291.
    1. Krousel-Wood M., Joyce C., Holt E. W., et al. Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension. Pharmacotherapy. 2013;33(8):798–811. doi: 10.1002/phar.1275.
    1. Krousel-Wood M., Muntner P., Jannu A., Desalvo K., Re R. N. Reliability of a medication adherence measure in an outpatient setting. The American Journal of the Medical Sciences. 2005;330(3):128–133. doi: 10.1097/00000441-200509000-00006.
    1. Culig J., Leppée M. From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Collegium Antropologicum. 2014;38(1):55–62.
    1. Toll B. A., McKee S. A., Martin D. J., Jatlow P., O'Malley S. S. Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. Nicotine and Tobacco Research. 2007;9(5):597–605. doi: 10.1080/14622200701239662.
    1. Morisky D. E., Green L. W., Levine D. M. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986;24(1):67–74. doi: 10.1097/00005650-198601000-00007.
    1. Thompson K., Kulkarni J., Sergejew A. A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research. 2000;42(3):241–247. doi: 10.1016/S0920-9964(99)00130-9.
    1. Liu H., Golin C. E., Miller L. G., et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine. 2001;134(10):968–977. doi: 10.7326/0003-4819-134-10-200105150-00011.
    1. Bosworth H. Improving Patient Treatment Adherence: A Clinician's Guide. New York, NY, USA: Springer; 2010.
    1. Rapoff M. A. Adherence to Pediatric Medical Regimens. 2nd. New York, NY, USA: Springer; 2010. (Issues in Clinical Child Psychology).
    1. Modi A. C., Lim C. S., Yu N., Geller D., Wagner M. H., Quittner A. L. A multi-method assessment of treatment adherence for children with cystic fibrosis. Journal of Cystic Fibrosis. 2006;5(3):177–185. doi: 10.1016/j.jcf.2006.03.002.
    1. Llabre M. M., Weaver K. E., Durán R. E., Antoni M. H., McPherson-Baker S., Schneiderman N. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care and STDs. 2006;20(10):701–711. doi: 10.1089/apc.2006.20.701.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa